Dispute arises over selection of AstraZeneca's 50 wholesalers

Published: 2003-08-01 07:00:00

Updated: 2003-08-01 07:00:00

The recent AstraZeneca's selection criteria of 50 wholesalers who will be dealing with its pharmaceutical business has been under fire from many OTC wholesalers, although the multination firm said that the criteria was made available based on scientific and objective data collected from its own s...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK